Richard M. Johnson President and Chief Executive Officer, Parenteral Drug Association Martin VanTrieste Chairman of the Board, Parenteral Drug Association (PDA) Andrew D. Skibo Head of Global Biologics Operations & Global Engineering, AstraZeneca/MedImmune Moncef Slaoui Former Chairman of Vaccines, GlaxoSmithKline Guido Rasi Executive Director, European Medicines Agency Gil Roth President, Pharma & Biopharma Outsourcing Association John E. Bournas President and Chief Executive Officer, International Society for Pharmaceutical Engineering (ISPE) Maik Jornitz Chief Executive Officer, G-CON Manufacturing Inc Sir Andrew Witty Former CEO of GlaxoSmithKline; Chancellor, University of Nottingham Rino Rappuoli Chief Scientist and Head of External R&D, GSK Vaccines James Agalloco President, Agalloco & Associates John Aunins Executive Vice President of Bioprocess & Manufacturing and Chief Technology Officer, Seres Therapeutics Jim Breen Vice President, Lead Biologic Expansion, Johnson & Johnson Carsten Brockmeyer Chief Executive Officer, Formycon AG Stephen T. Colgan Senior Director, Pfizer Worldwide Research and Development Fiona Greer Global Director, BioPharma Services Development, SGS Ajaz S. Hussain President, National Institute for Pharmaceutical Technology & Education, Inc., and Founder, Advice & Solutions LLC Roman Ivanov Vice-president R&D, International business development, BIOCAD John Lambert Executive Vice President Emeritus & Distinguished Research Fellow, Immunogen Jim Miller Founder & President, PharmSource Niclas Nilsson Head of R&D Open Innovation, LEO Pharma Daniel O’Connor Expert Medical Assessor, UK Medicines and Healthcare products Regulatory Agency Diane Paskiet Director of Scientific Affairs, West Pharmaceutical Services Cornell Stamoran Vice President of Corporate Strategy, Catalent Pharma Solutions Bernhardt L. Trout Raymond F. Baddour, ScD, (1949) Professor of Chemical Engineering, Massachusetts Institute of Technology
